Wei Song

This inventor holds 13 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Jiangnan University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Iview Therapeutics, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Song. Retrieved from https://idiyas.com/inventor/wei-song-nuvtjmbh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 92.3

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Lianyungang, CN (2022)
Jiangsu, CN (2014 - 2024)
Wuxi, CN (2023 - 2024)

Company Filing History:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

1 out of 9

Iview Therapeutics, Inc.

patents

4. 1 out of 3

Jiangsu Chiatai Tianqing Pharmaceutical Co., Ltd.

patents

5. 1 out of 42

Shanghai Institute of Pharmaceutical Industry

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545938 - METHOD FOR EFFICIENTLY PRODUCING L-HOMOPHENYLALANINE AND STRAIN PRODUCING L-HOMOPHENYLALANINE (2026-02-10),

2. 12508258 - Quinoline derivative for treating rheumatoid arthritis (2025-12-30),

3. 12398408 - Recombinantfor producing glutarate, construction method and use thereof (2025-08-26),

4. 12336996 - Drug combination containing TLR7 agonist (2025-06-24),

5. 12312612 - Acid phosphatase mutants and methods of using the same (2025-05-27),

6. 12195468 - TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof (2025-01-14),

7. 12128047 - TLR7 agonist and pharmaceutical combination thereof for treating lung cancer (2024-10-29),

8. 11986491 - Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases (2024-05-21),

9. 11976267 - Recombinantstrain for producing succinic acid and construction method thereof (2024-05-07),

10. 11781118 - Preparation of L-amino acid deaminase mutant and application thereof (2023-10-10),

11. 11534398 - Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases (2022-12-27),

12. 10308919 - Method for preparing ascorbic acid-2-phosphate using a recombinant strain (2019-06-04),

13. 8829039 - Dihydroindolinone derivatives (2014-09-09),

Title: Innovations and Contributions of Inventor Wei Song

Introduction

Wei Song is a notable inventor based in Jiangsu, China, recognized for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, he has made remarkable advancements in the production of glutarate and the treatment of hepatitis B virus infections.

Latest Patents

One of Wei Song's latest patents is focused on a recombinant method for producing glutarate. This invention involves constructing a double-plasmid recombinant bacterium that co-expresses an aldehyde synthase gene, an amine oxidase gene, and an aldehyde dehydrogenase gene. The process optimizes various conditions to achieve efficient production of glutarate from L-lysine. Another significant patent involves a drug combination containing a TLR7 agonist, which is effective in treating hepatitis B virus infections. This combination utilizes a specific compound alongside entecavir, demonstrating a strong anti-hepatitis B virus effect.

Career Highlights

Wei Song has had a distinguished career, working with prominent institutions such as Jiangnan University and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work has not only contributed to academic research but has also had practical applications in the pharmaceutical industry.

Collaborations

Throughout his career, Wei Song has collaborated with esteemed colleagues, including Xiulai Chen and Hongjiang Xu. These partnerships have fostered innovation and have been instrumental in advancing his research projects.

Conclusion

Wei Song's innovative work in biotechnology, particularly in the production of glutarate and hepatitis B treatments, showcases his significant impact on the field. His contributions continue to influence both research and practical applications in medicine.

Profile summary based on public USPTO records.